Placental Nanoparticle Uptake-On-a-Chip: The Impact of Trophoblast Syncytialization and Shear Stress

The placenta is a dynamic and complex organ that plays an essential role in the health and development of the fetus. Placental disorders can affect the health of both the mother and the fetus. There is currently an unmet clinical need to develop nanoparticle-based therapies to target and treat place...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular pharmaceutics 2022-11, Vol.19 (11), p.3757-3769
Hauptverfasser: Abostait, Amr, Tyrrell, Jack, Abdelkarim, Mahmoud, Shojaei, Shahla, Tse, Wai Hei, El-Sherbiny, Ibrahim M., Keijzer, Richard, Labouta, Hagar I.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3769
container_issue 11
container_start_page 3757
container_title Molecular pharmaceutics
container_volume 19
creator Abostait, Amr
Tyrrell, Jack
Abdelkarim, Mahmoud
Shojaei, Shahla
Tse, Wai Hei
El-Sherbiny, Ibrahim M.
Keijzer, Richard
Labouta, Hagar I.
description The placenta is a dynamic and complex organ that plays an essential role in the health and development of the fetus. Placental disorders can affect the health of both the mother and the fetus. There is currently an unmet clinical need to develop nanoparticle-based therapies to target and treat placental disorders. However, little is known about the interaction of nanoparticles (NPs) with the human placenta under biomimetic conditions. Specifically, the impact of shear stress exerted on the trophoblasts (placental epithelial cells) by the maternal blood flow, the gradual fusion of the trophoblasts along the gestation period (syncytialization), and the impact of microvilli formation on the cell uptake of NPs is not known. To this end, we designed dynamic placenta-on-a-chip models using BeWo cells to recapitulate the micro-physiological environment, and we induced different degrees of syncytialization via chemical induction with forskolin. We characterized the degree of syncytialization quantitatively by measuring beta human chorionic gonadotropin (β-hCG) secretion, as well as qualitatively by immunostaining the tight junction protein, ZO-1, and counter nuclear staining. We also characterized microvilli formation under static and dynamic conditions via F-actin staining. We used these models to measure the cell uptake of chondroitin sulfate a binding protein (CSA) conjugated and control liposomes using confocal microscopy, followed by image analysis. Interestingly, exposure of the cells to a dynamic flow of media intrinsically induced syncytialization and microvilli formation compared to static controls. Under dynamic conditions, BeWo cells produced more β-hCG in conditions that increased the cell exposure time to forskolin (p < 0.005). Our cell uptake results clearly show a combined effect of the exerted shear stress and forskolin treatment on the cell uptake of liposomes as uptake increased in forskolin exposed conditions (p < 0.05). Overall, the difference in the extent of cell uptake of liposomes among the different conditions clearly displays a need for the development of dynamic models of the placenta that consider the changes in the placental cell phenotype along the gestation period, including syncytialization, microvilli formation, and the expression of different transport and uptake receptors. Knowledge generated from this work will inform future research aiming at developing drug delivery systems targeting the placenta.
doi_str_mv 10.1021/acs.molpharmaceut.2c00216
format Article
fullrecord <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_acs_molpharmaceut_2c00216</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>f3913389</sourcerecordid><originalsourceid>FETCH-LOGICAL-a340t-71836b438a59edcb591ee00ba757390e970c9cc42d7acebf833921e01dbbc0e13</originalsourceid><addsrcrecordid>eNqNkM9KAzEQh4MoWKvvEB8gNdnsdjfepPinUKzQ9rxMsll2azZZkvRQn96UiuDN0wzM7xtmPoTuGZ0xmrEHUGE2ODN24AdQ-hBnmaJpML9AE1bknFRcZJe_fZVfo5sQ9imSFxmfoObDJMxGMPgdrBvBx14ZjXdjhE9N1pYAWXT9-Ii3ncbLYQQVsWvx1ruxc9JAiHhztOoYezD9F8TeWQy2wZtOg8eb6HUIt-iqBRP03U-dot3L83bxRlbr1-XiaUWA5zSSklV8LnNeQSF0o2QhmNaUSiiLkguqRUmVUCrPmjLdLNuKp9-YpqyRUlHN-BSJ817lXQhet_Xo-wH8sWa0Pumqk676j676R1diizN7iuzdwdt06T-4b_92eEI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Placental Nanoparticle Uptake-On-a-Chip: The Impact of Trophoblast Syncytialization and Shear Stress</title><source>ACS Publications</source><creator>Abostait, Amr ; Tyrrell, Jack ; Abdelkarim, Mahmoud ; Shojaei, Shahla ; Tse, Wai Hei ; El-Sherbiny, Ibrahim M. ; Keijzer, Richard ; Labouta, Hagar I.</creator><creatorcontrib>Abostait, Amr ; Tyrrell, Jack ; Abdelkarim, Mahmoud ; Shojaei, Shahla ; Tse, Wai Hei ; El-Sherbiny, Ibrahim M. ; Keijzer, Richard ; Labouta, Hagar I.</creatorcontrib><description>The placenta is a dynamic and complex organ that plays an essential role in the health and development of the fetus. Placental disorders can affect the health of both the mother and the fetus. There is currently an unmet clinical need to develop nanoparticle-based therapies to target and treat placental disorders. However, little is known about the interaction of nanoparticles (NPs) with the human placenta under biomimetic conditions. Specifically, the impact of shear stress exerted on the trophoblasts (placental epithelial cells) by the maternal blood flow, the gradual fusion of the trophoblasts along the gestation period (syncytialization), and the impact of microvilli formation on the cell uptake of NPs is not known. To this end, we designed dynamic placenta-on-a-chip models using BeWo cells to recapitulate the micro-physiological environment, and we induced different degrees of syncytialization via chemical induction with forskolin. We characterized the degree of syncytialization quantitatively by measuring beta human chorionic gonadotropin (β-hCG) secretion, as well as qualitatively by immunostaining the tight junction protein, ZO-1, and counter nuclear staining. We also characterized microvilli formation under static and dynamic conditions via F-actin staining. We used these models to measure the cell uptake of chondroitin sulfate a binding protein (CSA) conjugated and control liposomes using confocal microscopy, followed by image analysis. Interestingly, exposure of the cells to a dynamic flow of media intrinsically induced syncytialization and microvilli formation compared to static controls. Under dynamic conditions, BeWo cells produced more β-hCG in conditions that increased the cell exposure time to forskolin (p &lt; 0.005). Our cell uptake results clearly show a combined effect of the exerted shear stress and forskolin treatment on the cell uptake of liposomes as uptake increased in forskolin exposed conditions (p &lt; 0.05). Overall, the difference in the extent of cell uptake of liposomes among the different conditions clearly displays a need for the development of dynamic models of the placenta that consider the changes in the placental cell phenotype along the gestation period, including syncytialization, microvilli formation, and the expression of different transport and uptake receptors. Knowledge generated from this work will inform future research aiming at developing drug delivery systems targeting the placenta.</description><identifier>ISSN: 1543-8384</identifier><identifier>EISSN: 1543-8392</identifier><identifier>DOI: 10.1021/acs.molpharmaceut.2c00216</identifier><language>eng</language><publisher>American Chemical Society</publisher><ispartof>Molecular pharmaceutics, 2022-11, Vol.19 (11), p.3757-3769</ispartof><rights>2022 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a340t-71836b438a59edcb591ee00ba757390e970c9cc42d7acebf833921e01dbbc0e13</citedby><cites>FETCH-LOGICAL-a340t-71836b438a59edcb591ee00ba757390e970c9cc42d7acebf833921e01dbbc0e13</cites><orcidid>0000-0002-8179-437X ; 0000-0001-7344-5893</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00216$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.molpharmaceut.2c00216$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids></links><search><creatorcontrib>Abostait, Amr</creatorcontrib><creatorcontrib>Tyrrell, Jack</creatorcontrib><creatorcontrib>Abdelkarim, Mahmoud</creatorcontrib><creatorcontrib>Shojaei, Shahla</creatorcontrib><creatorcontrib>Tse, Wai Hei</creatorcontrib><creatorcontrib>El-Sherbiny, Ibrahim M.</creatorcontrib><creatorcontrib>Keijzer, Richard</creatorcontrib><creatorcontrib>Labouta, Hagar I.</creatorcontrib><title>Placental Nanoparticle Uptake-On-a-Chip: The Impact of Trophoblast Syncytialization and Shear Stress</title><title>Molecular pharmaceutics</title><addtitle>Mol. Pharmaceutics</addtitle><description>The placenta is a dynamic and complex organ that plays an essential role in the health and development of the fetus. Placental disorders can affect the health of both the mother and the fetus. There is currently an unmet clinical need to develop nanoparticle-based therapies to target and treat placental disorders. However, little is known about the interaction of nanoparticles (NPs) with the human placenta under biomimetic conditions. Specifically, the impact of shear stress exerted on the trophoblasts (placental epithelial cells) by the maternal blood flow, the gradual fusion of the trophoblasts along the gestation period (syncytialization), and the impact of microvilli formation on the cell uptake of NPs is not known. To this end, we designed dynamic placenta-on-a-chip models using BeWo cells to recapitulate the micro-physiological environment, and we induced different degrees of syncytialization via chemical induction with forskolin. We characterized the degree of syncytialization quantitatively by measuring beta human chorionic gonadotropin (β-hCG) secretion, as well as qualitatively by immunostaining the tight junction protein, ZO-1, and counter nuclear staining. We also characterized microvilli formation under static and dynamic conditions via F-actin staining. We used these models to measure the cell uptake of chondroitin sulfate a binding protein (CSA) conjugated and control liposomes using confocal microscopy, followed by image analysis. Interestingly, exposure of the cells to a dynamic flow of media intrinsically induced syncytialization and microvilli formation compared to static controls. Under dynamic conditions, BeWo cells produced more β-hCG in conditions that increased the cell exposure time to forskolin (p &lt; 0.005). Our cell uptake results clearly show a combined effect of the exerted shear stress and forskolin treatment on the cell uptake of liposomes as uptake increased in forskolin exposed conditions (p &lt; 0.05). Overall, the difference in the extent of cell uptake of liposomes among the different conditions clearly displays a need for the development of dynamic models of the placenta that consider the changes in the placental cell phenotype along the gestation period, including syncytialization, microvilli formation, and the expression of different transport and uptake receptors. Knowledge generated from this work will inform future research aiming at developing drug delivery systems targeting the placenta.</description><issn>1543-8384</issn><issn>1543-8392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqNkM9KAzEQh4MoWKvvEB8gNdnsdjfepPinUKzQ9rxMsll2azZZkvRQn96UiuDN0wzM7xtmPoTuGZ0xmrEHUGE2ODN24AdQ-hBnmaJpML9AE1bknFRcZJe_fZVfo5sQ9imSFxmfoObDJMxGMPgdrBvBx14ZjXdjhE9N1pYAWXT9-Ii3ncbLYQQVsWvx1ruxc9JAiHhztOoYezD9F8TeWQy2wZtOg8eb6HUIt-iqBRP03U-dot3L83bxRlbr1-XiaUWA5zSSklV8LnNeQSF0o2QhmNaUSiiLkguqRUmVUCrPmjLdLNuKp9-YpqyRUlHN-BSJ817lXQhet_Xo-wH8sWa0Pumqk676j676R1diizN7iuzdwdt06T-4b_92eEI</recordid><startdate>20221107</startdate><enddate>20221107</enddate><creator>Abostait, Amr</creator><creator>Tyrrell, Jack</creator><creator>Abdelkarim, Mahmoud</creator><creator>Shojaei, Shahla</creator><creator>Tse, Wai Hei</creator><creator>El-Sherbiny, Ibrahim M.</creator><creator>Keijzer, Richard</creator><creator>Labouta, Hagar I.</creator><general>American Chemical Society</general><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-8179-437X</orcidid><orcidid>https://orcid.org/0000-0001-7344-5893</orcidid></search><sort><creationdate>20221107</creationdate><title>Placental Nanoparticle Uptake-On-a-Chip: The Impact of Trophoblast Syncytialization and Shear Stress</title><author>Abostait, Amr ; Tyrrell, Jack ; Abdelkarim, Mahmoud ; Shojaei, Shahla ; Tse, Wai Hei ; El-Sherbiny, Ibrahim M. ; Keijzer, Richard ; Labouta, Hagar I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a340t-71836b438a59edcb591ee00ba757390e970c9cc42d7acebf833921e01dbbc0e13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abostait, Amr</creatorcontrib><creatorcontrib>Tyrrell, Jack</creatorcontrib><creatorcontrib>Abdelkarim, Mahmoud</creatorcontrib><creatorcontrib>Shojaei, Shahla</creatorcontrib><creatorcontrib>Tse, Wai Hei</creatorcontrib><creatorcontrib>El-Sherbiny, Ibrahim M.</creatorcontrib><creatorcontrib>Keijzer, Richard</creatorcontrib><creatorcontrib>Labouta, Hagar I.</creatorcontrib><collection>CrossRef</collection><jtitle>Molecular pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abostait, Amr</au><au>Tyrrell, Jack</au><au>Abdelkarim, Mahmoud</au><au>Shojaei, Shahla</au><au>Tse, Wai Hei</au><au>El-Sherbiny, Ibrahim M.</au><au>Keijzer, Richard</au><au>Labouta, Hagar I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Placental Nanoparticle Uptake-On-a-Chip: The Impact of Trophoblast Syncytialization and Shear Stress</atitle><jtitle>Molecular pharmaceutics</jtitle><addtitle>Mol. Pharmaceutics</addtitle><date>2022-11-07</date><risdate>2022</risdate><volume>19</volume><issue>11</issue><spage>3757</spage><epage>3769</epage><pages>3757-3769</pages><issn>1543-8384</issn><eissn>1543-8392</eissn><abstract>The placenta is a dynamic and complex organ that plays an essential role in the health and development of the fetus. Placental disorders can affect the health of both the mother and the fetus. There is currently an unmet clinical need to develop nanoparticle-based therapies to target and treat placental disorders. However, little is known about the interaction of nanoparticles (NPs) with the human placenta under biomimetic conditions. Specifically, the impact of shear stress exerted on the trophoblasts (placental epithelial cells) by the maternal blood flow, the gradual fusion of the trophoblasts along the gestation period (syncytialization), and the impact of microvilli formation on the cell uptake of NPs is not known. To this end, we designed dynamic placenta-on-a-chip models using BeWo cells to recapitulate the micro-physiological environment, and we induced different degrees of syncytialization via chemical induction with forskolin. We characterized the degree of syncytialization quantitatively by measuring beta human chorionic gonadotropin (β-hCG) secretion, as well as qualitatively by immunostaining the tight junction protein, ZO-1, and counter nuclear staining. We also characterized microvilli formation under static and dynamic conditions via F-actin staining. We used these models to measure the cell uptake of chondroitin sulfate a binding protein (CSA) conjugated and control liposomes using confocal microscopy, followed by image analysis. Interestingly, exposure of the cells to a dynamic flow of media intrinsically induced syncytialization and microvilli formation compared to static controls. Under dynamic conditions, BeWo cells produced more β-hCG in conditions that increased the cell exposure time to forskolin (p &lt; 0.005). Our cell uptake results clearly show a combined effect of the exerted shear stress and forskolin treatment on the cell uptake of liposomes as uptake increased in forskolin exposed conditions (p &lt; 0.05). Overall, the difference in the extent of cell uptake of liposomes among the different conditions clearly displays a need for the development of dynamic models of the placenta that consider the changes in the placental cell phenotype along the gestation period, including syncytialization, microvilli formation, and the expression of different transport and uptake receptors. Knowledge generated from this work will inform future research aiming at developing drug delivery systems targeting the placenta.</abstract><pub>American Chemical Society</pub><doi>10.1021/acs.molpharmaceut.2c00216</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-8179-437X</orcidid><orcidid>https://orcid.org/0000-0001-7344-5893</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1543-8384
ispartof Molecular pharmaceutics, 2022-11, Vol.19 (11), p.3757-3769
issn 1543-8384
1543-8392
language eng
recordid cdi_crossref_primary_10_1021_acs_molpharmaceut_2c00216
source ACS Publications
title Placental Nanoparticle Uptake-On-a-Chip: The Impact of Trophoblast Syncytialization and Shear Stress
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T20%3A46%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Placental%20Nanoparticle%20Uptake-On-a-Chip:%20The%20Impact%20of%20Trophoblast%20Syncytialization%20and%20Shear%20Stress&rft.jtitle=Molecular%20pharmaceutics&rft.au=Abostait,%20Amr&rft.date=2022-11-07&rft.volume=19&rft.issue=11&rft.spage=3757&rft.epage=3769&rft.pages=3757-3769&rft.issn=1543-8384&rft.eissn=1543-8392&rft_id=info:doi/10.1021/acs.molpharmaceut.2c00216&rft_dat=%3Cacs_cross%3Ef3913389%3C/acs_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true